|
Transplantation
Citations 431-440 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
- Grazia Maria Spaggiari, Andrea Capobianco, Stelvio Becchetti, Maria Cristina Mingari, and Lorenzo Moretta
Blood 2006; 107: 1484-1490.
[Abstract]
[Full text]
[PDF]
Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes
- Shoshana Morecki, Horst Lindhofer, Elena Yacovlev, Yael Gelfand, and Shimon Slavin
Blood 2006; 107: 1564-1569.
[Abstract]
[Full text]
[PDF]
Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia
- Bipin N. Savani, Katayoun Rezvani, Stephan Mielke, Aldemar Montero, Roger Kurlander, Charles S. Carter, Susan Leitman, Elizabeth J. Read, Richard Childs, and A. John Barrett
Blood 2006; 107: 1688-1695.
[Abstract]
[Full text]
[PDF]
Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network
- Ismé de Kleer, Bas Vastert, Mark Klein, Gijs Teklenburg, Ger Arkesteijn, Gisella Puga Yung, Salvo Albani, Wietse Kuis, Nico Wulffraat, and Berent Prakken
Blood 2006; 107: 1696-1702.
[Abstract]
[Full text]
[PDF]
Absence of 7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine
- Elisha Waldman, Sydney X. Lu, Vanessa M. Hubbard, Adam A. Kochman, Jeffrey M. Eng, Theis H. Terwey, Stephanie J. Muriglan, Theo D. Kim, Glenn Heller, George F. Murphy, Chen Liu, Onder Alpdogan, and Marcel R. M. van den Brink
Blood 2006; 107: 1703-1711.
[Abstract]
[Full text]
[PDF]
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation
- Hanna J. Khoury, Fausto R. Loberiza, Jr, Olle Ringdén, A. John Barrett, Brian J. Bolwell, Jean-Yves Cahn, Richard E. Champlin, Robert Peter Gale, Gregory A. Hale, Alvaro Urbano-Ispizua, Rodrigo Martino, Philip L. McCarthy, Pierre Tiberghien, Leo F. Verdonck, and Mary M. Horowitz
Blood 2006; 107: 1712-1716.
[Abstract]
[Full text]
[PDF]
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
- Kathrin Rieger, Christoph Loddenkemper, Jochem Maul, Thomas Fietz, Daniel Wolff, Harald Terpe, Beate Steiner, Erika Berg, Stephan Miehlke, Martin Bornhäuser, Thomas Schneider, Martin Zeitz, Harald Stein, Eckhard Thiel, Rainer Duchmann, and Lutz Uharek
Blood 2006; 107: 1717-1723.
[Abstract]
[Full text]
[PDF]
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study
- Julio Delgado, Kirsty Thomson, Nigel Russell, Joanne Ewing, Wendy Stewart, Gordon Cook, Stephen Devereux, Richard Lovell, Rajesh Chopra, David I. Marks, Stephen Mackinnon, and Donald W. Milligan
Blood 2006; 107: 1724-1730.
[Abstract]
[Full text]
[PDF]
Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells
- Jeroen J. A. Coenen, Hans J. P. M. Koenen, Esther van Rijssen, Luuk B. Hilbrands, and Irma Joosten
Blood 2006; 107: 1018-1023.
[Abstract]
[Full text]
[PDF]
Hematopoietic stem cell exhaustion impacted by p18INK4C and p21Cip1/Waf1 in opposite manners
- Hui Yu, Youzhong Yuan, Hongmei Shen, and Tao Cheng
Blood 2006; 107: 1200-1206.
[Abstract]
[Full text]
[PDF]
|
|